Exposure, Metabolomics and Biomarkers, and Health Outcomes, Part II

CME/MOC: 1.5
TRACK: Regulatory, Legal, Military, and Governmental OEM

Phillip K. Hopke, PhD, Clarkson University, Potsdam, NY
Timothy M. Mallon, MD, MS, MPH, FACOEM, US Navy/ Uniformed Services University, Bethesda, MD
Professor Julie Thakar, PhD, University of Rochester, Rochester, NY
Mark Utell, MD, Strong Memorial Hospital and the University of Rochester, Rochester, NY
Collynn Woeller, PhD, University of Rochester, Rochester, NY

This session will help participants understand the tools used to identify molecular signatures associated with deployment exposures and to identify biological processes and disease pathways that are impacted. The session will discuss epigenitics, microRNAs, and inflammatory biomarkers, and changes to pre- and post-deployment, and the relationship with health outcomes in deployed service memebrs. Advances in large database statistical applications will be examined. This session was organized by the Federal and Military Occupational and Environmental Medicine Special Interest Section.